Spots Global Cancer Trial Database for malignant mesothelioma
Every month we try and update this database with for malignant mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | NCT00005636 | Malignant Mesot... | cisplatin pemetrexed diso... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery | NCT00003723 | Malignant Mesot... | gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. | NCT00996567 | Cancer | Cetuximab (Erbi... | 18 Years - | University Hospital, Ghent | |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma | NCT00398138 | Leukemia Lung Cancer Malignant Mesot... Myelodysplastic... Primary Periton... | WT-1 analog pep... incomplete Freu... sargramostim polymerase chai... flow cytometry immunoenzyme te... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | NCT00066651 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma | NCT00354393 | Malignant Mesot... | Cisplatin Methotrexate Vinorelbine dit... Adjuvant therap... Conventional su... Neoadjuvant The... 3-dimensional c... Intensity-modul... | - 75 Years | The Cleveland Clinic | |
| Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma | NCT00458913 | Malignant Mesot... | bortezomib cisplatin | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma | NCT00787410 | Mesothelioma | ZD1839 | 18 Years - | AstraZeneca | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma | NCT00398138 | Leukemia Lung Cancer Malignant Mesot... Myelodysplastic... Primary Periton... | WT-1 analog pep... incomplete Freu... sargramostim polymerase chai... flow cytometry immunoenzyme te... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. | NCT00996567 | Cancer | Cetuximab (Erbi... | 18 Years - | University Hospital, Ghent | |
| Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery | NCT00541073 | Malignant Mesot... | vitamin B12 cisplatin pemetrexed diso... gene expression... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00227630 | Malignant Mesot... | cisplatin pemetrexed diso... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery | NCT03007030 | CD30-Positive N... Malignant Mesot... | Brentuximab Ved... Laboratory Biom... | 18 Years - | M.D. Anderson Cancer Center | |
| Collecting Tumor Samples From Patients With Gynecological Tumors | NCT00897442 | Borderline Ovar... Borderline Ovar... Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Childhood Embry... Childhood Malig... Endometrioid St... Gestational Tro... Malignant Mesot... Malignant Ovari... Melanoma Neoplasm of Unc... Ovarian Brenner... Ovarian Clear C... Ovarian Serous ... Paget Disease o... Recurrent Cervi... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... Stage I Ovarian... Stage I Uterine... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IB Cervic... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage II Uterin... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage III Borde... Stage III Cervi... Stage III Uteri... Stage III Vagin... Stage III Vulva... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Border... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Stage IVB Vulva... Uterine Corpus ... Uterine Corpus ... Vulvar Squamous... | Laboratory Biom... | - | GOG Foundation | |
| S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery | NCT00003723 | Malignant Mesot... | gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma | NCT00003974 | Lung Cancer Malignant Mesot... | lung tumor asso... DetoxPC chemotherapy cyclophosphamid... | 20 Years - 70 Years | Roswell Park Cancer Institute | |
| Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107 | NCT00898547 | Malignant Mesot... | immunoenzyme te... laboratory biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma | NCT00054002 | Malignant Mesot... | adjuvant therap... conventional su... porfimer sodium | 18 Years - | Roswell Park Cancer Institute | |
| Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer | NCT00024271 | Malignant Mesot... | recombinant int... cisplatin doxorubicin hyd... gemcitabine hyd... mitomycin C conventional su... hyperthermia tr... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib in Treating Patients With Malignant Pleural Mesothelioma | NCT00513877 | Malignant Mesot... | bortezomib quality-of-life... | 18 Years - | Cancer Trials Ireland | |
| Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | NCT00004254 | Malignant Mesot... | raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Collecting Tumor Samples From Patients With Gynecological Tumors | NCT00897442 | Borderline Ovar... Borderline Ovar... Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Childhood Embry... Childhood Malig... Endometrioid St... Gestational Tro... Malignant Mesot... Malignant Ovari... Melanoma Neoplasm of Unc... Ovarian Brenner... Ovarian Clear C... Ovarian Serous ... Paget Disease o... Recurrent Cervi... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... Stage I Ovarian... Stage I Uterine... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IB Cervic... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage II Uterin... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage III Borde... Stage III Cervi... Stage III Uteri... Stage III Vagin... Stage III Vulva... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Border... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Stage IVB Vulva... Uterine Corpus ... Uterine Corpus ... Vulvar Squamous... | Laboratory Biom... | - | GOG Foundation | |
| Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer | NCT00024076 | Lung Cancer Malignant Mesot... Metastatic Canc... Thymoma and Thy... | radiofrequency ... | - | Jonsson Comprehensive Cancer Center | |
| Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | NCT00005636 | Malignant Mesot... | cisplatin pemetrexed diso... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia | NCT00899613 | Malignant Mesot... Metastatic Canc... | laboratory biom... study of high r... | - | National Cancer Institute (NCI) | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite | NCT00897247 | Malignant Mesot... Pulmonary Compl... | microarray anal... protein express... proteomic profi... laboratory biom... | 25 Years - 80 Years | Barbara Ann Karmanos Cancer Institute | |
| An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma | NCT00787410 | Mesothelioma | ZD1839 | 18 Years - | AstraZeneca | |
| Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease | NCT00733252 | Lung Cancer Malignant Mesot... Metastatic Canc... Nonmalignant Ne... Precancerous Co... | bronchoscopic a... diagnostic bron... histopathologic... optical coheren... | - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery | NCT00253409 | Malignant Mesot... | chemotherapy adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura | NCT00004920 | Malignant Mesot... | cisplatin raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer | NCT00006981 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma | NCT00002465 | Breast Cancer Endometrial Can... Malignant Mesot... | megestrol aceta... | 18 Years - | National Cancer Institute (NCI) | |
| S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery | NCT00770120 | Malignant Mesot... | everolimus | 18 Years - 120 Years | SWOG Cancer Research Network | |
| A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. | NCT00996567 | Cancer | Cetuximab (Erbi... | 18 Years - | University Hospital, Ghent | |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma | NCT00398138 | Leukemia Lung Cancer Malignant Mesot... Myelodysplastic... Primary Periton... | WT-1 analog pep... incomplete Freu... sargramostim polymerase chai... flow cytometry immunoenzyme te... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers | NCT02349412 | Liver Cancer Anxiety Disorde... Depression Small Cell Lung... Extrahepatic Bi... Malignant Mesot... Pancreatic Canc... Esophageal Canc... Gastric Cancer Non-small Cell ... | Early palliativ... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients | NCT02300883 | Malignant Mesot... | - | Istituto Clinico Humanitas | ||
| Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma | NCT00003508 | Malignant Mesot... | Antineoplaston ... | 1 Year - 120 Years | Burzynski Research Institute | |
| Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery | NCT03678350 | Malignant Mesot... Non-Small Cell ... Pleural Disorde... | Light Dosimetry... Photodynamic Th... Porfimer Sodium | 18 Years - | Roswell Park Cancer Institute | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00334594 | Malignant Mesot... | Cisplatin Pemetrexed Therapeutic con... Radiotherapy | 18 Years - 69 Years | Swiss Group for Clinical Cancer Research | |
| Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma | NCT00821860 | Malignant Mesot... Metastatic Canc... | talc therapeutic tho... therapeutic vid... | 18 Years - | Papworth Hospital NHS Foundation Trust | |
| The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma | NCT01655888 | Malignant Mesot... | Tremelimumab | 18 Years - | Azienda Ospedaliera Universitaria Senese | |
| Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery | NCT03678350 | Malignant Mesot... Non-Small Cell ... Pleural Disorde... | Light Dosimetry... Photodynamic Th... Porfimer Sodium | 18 Years - | Roswell Park Cancer Institute | |
| Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma | NCT00354393 | Malignant Mesot... | Cisplatin Methotrexate Vinorelbine dit... Adjuvant therap... Conventional su... Neoadjuvant The... 3-dimensional c... Intensity-modul... | - 75 Years | The Cleveland Clinic | |
| Capecitabine in Treating Patients With Malignant Mesothelioma | NCT00004183 | Malignant Mesot... | capecitabine | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery | NCT03678350 | Malignant Mesot... Non-Small Cell ... Pleural Disorde... | Light Dosimetry... Photodynamic Th... Porfimer Sodium | 18 Years - | Roswell Park Cancer Institute | |
| Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma | NCT04173338 | Non Small Cell ... Non-squamous No... Urothelial Carc... Malignant Mesot... | Cabozantinib Pemetrexed | 18 Years - | Augusta University | |
| Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00075699 | Malignant Mesot... | cisplatin mitomycin C vincristine sul... vinorelbine tar... pain therapy psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma | NCT00003508 | Malignant Mesot... | Antineoplaston ... | 1 Year - 120 Years | Burzynski Research Institute | |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer | NCT00006981 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer | NCT00372840 | Breast Cancer Colorectal Canc... Lung Cancer Malignant Mesot... Prostate Cancer Psychosocial Ef... Thymoma and Thy... | educational int... psychosocial as... quality-of-life... | 18 Years - 120 Years | Fox Chase Cancer Center | |
| Rehabilitation by Effort for Patients With Advanced Bronchial Cancer | NCT03684486 | Bronchial Cance... Malignant Mesot... | rehabilitation ... | 18 Years - 70 Years | University Hospital, Toulouse | |
| A Study of LY3023414 in Participants With Advanced Cancer | NCT01655225 | Advanced Cancer Metastatic Canc... Non-Hodgkin's L... Metastatic Brea... Malignant Mesot... Non-small Cell ... | LY3023414 Midazolam Fulvestrant Pemetrexed Cisplatin Abemaciclib Letrozole | 18 Years - | Eli Lilly and Company | |
| Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma | NCT00458913 | Malignant Mesot... | bortezomib cisplatin | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung | NCT00030745 | Malignant Mesot... | cisplatin gemcitabine hyd... conventional su... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso | NCT02580747 | Malignant Mesot... Pancreatic Canc... Ovarian Tumor Triple Negative... Endometrial Can... Other Mesotheli... | anti-meso-CAR v... | 18 Years - 70 Years | Chinese PLA General Hospital | |
| Dendritic Cell Vaccination for Patients With Solid Tumors | NCT01291420 | Glioblastoma Renal Cell Carc... Sarcomas Breast Cancers Malignant Mesot... Colorectal Tumo... | autologous dend... | 18 Years - | University Hospital, Antwerp | |
| Rehabilitation by Effort for Patients With Advanced Bronchial Cancer | NCT03684486 | Bronchial Cance... Malignant Mesot... | rehabilitation ... | 18 Years - 70 Years | University Hospital, Toulouse | |
| Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | NCT00004254 | Malignant Mesot... | raltitrexed | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer | NCT00372840 | Breast Cancer Colorectal Canc... Lung Cancer Malignant Mesot... Prostate Cancer Psychosocial Ef... Thymoma and Thy... | educational int... psychosocial as... quality-of-life... | 18 Years - 120 Years | Fox Chase Cancer Center | |
| Bortezomib in Treating Patients With Malignant Pleural Mesothelioma | NCT00513877 | Malignant Mesot... | bortezomib quality-of-life... | 18 Years - | Cancer Trials Ireland | |
| Alanosine in Treating Patients With Cancer | NCT00062283 | Lung Cancer Malignant Mesot... Pancreatic Canc... Sarcoma | L-alanosine | 13 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy | NCT01085630 | Malignant Mesot... | pemetrexed diso... clinical observ... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma | NCT00634205 | Malignant Mesot... | Valproate plus ... | 18 Years - | European Lung Cancer Working Party | |
| First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin | NCT03507452 | Advanced Recurr... Advanced Recurr... Advanced Recurr... Advanced Pancre... | BAY2287411 BAY2287411 | 18 Years - | Bayer | |
| Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma | NCT00030459 | Malignant Mesot... | cisplatin mitomycin C vinblastine sul... vinorelbine tar... | - | National Cancer Institute (NCI) | |
| A Study of LY3023414 in Participants With Advanced Cancer | NCT01655225 | Advanced Cancer Metastatic Canc... Non-Hodgkin's L... Metastatic Brea... Malignant Mesot... Non-small Cell ... | LY3023414 Midazolam Fulvestrant Pemetrexed Cisplatin Abemaciclib Letrozole | 18 Years - | Eli Lilly and Company | |
| Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma | NCT04173338 | Non Small Cell ... Non-squamous No... Urothelial Carc... Malignant Mesot... | Cabozantinib Pemetrexed | 18 Years - | Augusta University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
